Cerebras Systems is sitting on a massive $25.4 billion backlog of customer orders for its wafer-scale AI chips, yet Wall Street analysts are increasingly recommending its quantum computing competitor IonQ as the better investment for 2026. The disconnect reveals a crucial tension in the AI hardware market: having enormous demand doesn't automatically translate to being the most attractive stock, especially when growth rates and financial health matter just as much as order books.

Why Is Cerebras' Backlog So Massive?

Cerebras specializes in building extraordinarily large chips designed to accelerate artificial intelligence (AI) training and inference, the process of running trained models to generate predictions or responses. The company's flagship product is the CS-3 platform, powered by the WSE-3 chip, a wafer-scale engine that processes data at speeds traditional processors cannot match. The backlog reflects genuine customer appetite; one OpenAI agreement alone accounts for a substantial portion of that $25.4 billion in future revenue.

In 2025, Cerebras generated nearly $510 million in revenue, a 75.7% increase from the prior year, demonstrating that the company is converting backlog into actual sales. The company maintains a gross margin of 39%, meaning it keeps roughly 39 cents of every dollar after manufacturing costs. However, the company's financial picture has darkened in 2026 as it invests heavily in scaling production to meet demand.

What's the Catch With Cerebras' Financial Health?

Despite the impressive backlog and revenue growth, Cerebras swung from profitability to losses in 2026. The company reported net income of close to $238 million in 2025, but further investment in scaling has pushed it back into the red this year. More concerning, its trailing-12-month free cash flow as of the second quarter of 2026 was negative $680 million, meaning the company is burning through cash faster than it generates it from operations.

The company does maintain a strong balance sheet in some respects. Its debt-to-equity ratio sits at approximately 0.1x, indicating minimal debt relative to shareholder equity. Its current ratio of 5.8x means it has $5.80 in short-term assets for every $1 of short-term obligations, providing a comfortable cushion for near-term expenses. Still, the negative free cash flow raises questions about how long the company can sustain aggressive expansion without additional funding.

Why Are Investors Choosing IonQ Over Cerebras?

IonQ develops quantum computing systems, a fundamentally different technology that uses quantum mechanics rather than traditional silicon to solve certain classes of problems. While Cerebras focuses on scaling classical AI hardware, IonQ is betting on an emerging technology that could eventually outperform traditional approaches for specific workloads. In the second quarter of 2026, IonQ reported 287% year-over-year revenue growth, far outpacing Cerebras' 74% growth rate.

IonQ's 2025 revenue reached approximately $130 million, growing 202% from the prior year. The company recently delivered systems to the Korea Institute of Science and reported its fifth consecutive quarter of record financial results. Like Cerebras, IonQ is unprofitable; it posted a net loss of close to $510 million in 2025, widening to over $1.3 billion on a trailing basis through the second quarter of 2026. However, IonQ carries no debt (a debt-to-equity ratio of 0.0x) and maintains a current ratio of 10.7x, suggesting stronger near-term financial flexibility.

How Should Investors Evaluate These Two Companies?

• Revenue Growth Trajectory: IonQ is expanding revenue at 287% year-over-year compared to Cerebras' 74%, indicating sharper momentum in customer adoption and market penetration despite starting from a smaller revenue base.
• Balance Sheet Strength: IonQ carries zero debt and maintains a 10.7x current ratio, while Cerebras has minimal debt but a lower current ratio of 5.8x, giving IonQ more financial flexibility to weather downturns or fund expansion.
• Cash Burn Rate: Cerebras is burning $680 million in free cash flow annually, while IonQ burns $484 million, making IonQ's cash consumption slightly more sustainable relative to its revenue base.
• Valuation Multiples: Cerebras trades at a forward price-to-earnings ratio of 148.1x and a price-to-sales ratio of 81.6x, while IonQ's price-to-sales ratio is 110.5x, suggesting Cerebras appears relatively cheaper on some metrics despite its larger backlog.
• Market Positioning: Cerebras operates in the crowded AI hardware market facing competition from established players, while IonQ targets the emerging quantum computing space with less direct competition but higher technological uncertainty.

The fundamental question investors face is whether to bet on Cerebras' proven demand and massive backlog or IonQ's explosive growth rate and cleaner balance sheet. Cerebras has the advantage of serving a market that already exists and is expanding rapidly. The company's $25.4 billion backlog represents real customer commitments, many from enterprise and government clients who need AI training infrastructure today.

However, IonQ's growth rate suggests it is winning market share faster and reaching more customers with each passing quarter. The company's recent partnership with CMC Microsystems to integrate quantum technology into research and industrial applications signals expanding use cases beyond its initial cloud-based offerings through Amazon and Microsoft.

What Do the Numbers Tell Us About Risk?

Both companies face distinct risks. Cerebras operates in an intensely competitive market where large, established technology firms command significant market share. Any disruption in its specialized manufacturing process for wafer-scale chips could delay product delivery to its global customer base. The company must also innovate rapidly to maintain performance advantages against traditional chip architectures.

IonQ faces different challenges. The company's history of operating losses and substantial capital requirements create financial risk. Scaling to high-volume commercial production remains uncertain, and competition from Amazon, IBM, and Microsoft in quantum computing is intensifying. Additionally, IonQ's recent acquisitions of SkyWater and Vector Atomic could strain management resources as the company integrates these businesses.

The backlog advantage Cerebras holds is real, but it does not guarantee superior stock performance. Investors increasingly recognize that growth rate, financial health, and market positioning matter as much as order books. Cerebras' massive backlog reflects genuine demand for AI training infrastructure, yet the company's accelerating cash burn and return to losses in 2026 temper enthusiasm. IonQ's faster growth, zero debt, and stronger current ratio suggest a company better positioned to fund its expansion without diluting shareholders through additional equity raises.